欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SK/H/0240/001
药品名称Sitagliptin/Metformin Krka 50 mg/850 mg film-coated tablets Sitagliptin/Metformin Krka 50 mg/1000 mg film-coated tablets
活性成分
    • Metformin hydrochloride 850.0 mg
    • Sitagliptin 50.0 mg
剂型Film-coated tablet
上市许可持有人Krka, d.d., Novo mesto Smarjeska cesta 6 8501 Slovenia
参考成员国 - 产品名称Slovakia (SK)
Sitagliptin/Metofrmin Krka 50 mg/850 mg filmom obalené tablety
互认成员国 - 产品名称
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
      Sitagliptin/Metformin Krka
    • Finland (FI)
    • Denmark (DK)
    • Belgium (BE)
      Sitagliptine/Metformine Krka 50 mg/850 mg filmomhulde tabletten
    • Iceland (IS)
      Sitagliptin/Metformin Krka
    • Ireland (IE)
    • Austria (AT)
      Sitagliptin/Metformin HCS 50 mg/850 mg Filmtabletten
许可日期2020/11/19
最近更新日期2024/11/13
药物ATC编码
    • A10BD07 metformin and sitagliptin
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase